Study in Taiwanese Subjects Identified as CYP2C19 Poor and Extensive Metabolizers Receiving Rosuvastatin
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to examine Taiwanese subjects identified as CYP2C19 poor
and extensive metabolizers while taking single and multiple dosing a rosuvastatin calcium.